Of note, BCR-ABL may also likely establish molecular crosstalk with other kinases such as JAK2 [199] and JAK2/STAT5 [174] to maintain CML LSC properties. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.